165 related articles for article (PubMed ID: 19635465)
1. Blockade of fear-induced antinociception with intra-amygdala infusion of midazolam: Influence of prior test experience.
Baptista D; Bussadori K; Nunes-de-Souza RL; Canto-de-Souza A
Brain Res; 2009 Oct; 1294():29-37. PubMed ID: 19635465
[TBL] [Abstract][Full Text] [Related]
2. Intra-periaqueductal gray matter injections of midazolam fail to alter anxiety in plus-maze experienced mice.
dos Reis LM; Canto-de-Souza A
Brain Res; 2008 Sep; 1231():93-102. PubMed ID: 18621039
[TBL] [Abstract][Full Text] [Related]
3. Concurrent nociceptive stimulation impairs the anxiolytic effect of midazolam injected into the periaqueductal gray in mice.
Mendes-Gomes J; Nunes-de-Souza RL
Brain Res; 2005 Jun; 1047(1):97-104. PubMed ID: 15893297
[TBL] [Abstract][Full Text] [Related]
4. Similar anxiolytic-like effects following intra-amygdala infusions of benzodiazepine receptor agonist and antagonist: evidence for the release of an endogenous benzodiazepine inverse agonist in mice exposed to elevated plus-maze test.
Barbalho CA; Nunes-de-Souza RL; Canto-de-Souza A
Brain Res; 2009 Apr; 1267():65-76. PubMed ID: 19268657
[TBL] [Abstract][Full Text] [Related]
5. A comparative study with two types of elevated plus-maze (transparent vs. opaque walls) on the anxiolytic effects of midazolam, one-trial tolerance and fear-induced analgesia.
Albrechet-Souza L; Oliveira AR; De Luca MC; Tomazini FM; Santos NR; Brandão ML
Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):571-9. PubMed ID: 15866360
[TBL] [Abstract][Full Text] [Related]
6. Enhanced dorsolateral periaqueductal gray activity counteracts the anxiolytic response to midazolam on the elevated plus-maze Trial 2 in rats.
Bertoglio LJ; Anzini C; Lino-de-Oliveira C; Carobrez AP
Behav Brain Res; 2005 Jul; 162(1):99-107. PubMed ID: 15922070
[TBL] [Abstract][Full Text] [Related]
7. The anterior cingulate cortex is a target structure for the anxiolytic-like effects of benzodiazepines assessed by repeated exposure to the elevated plus maze and Fos immunoreactivity.
Albrechet-Souza L; Borelli KG; Carvalho MC; Brandão ML
Neuroscience; 2009 Dec; 164(2):387-97. PubMed ID: 19699782
[TBL] [Abstract][Full Text] [Related]
8. Anxiety-induced antinociception in mice: effects of systemic and intra-amygdala administration of 8-OH-DPAT and midazolam.
Nunes-de-Souza RL; Canto-de-Souza A; da-Costa M; Fornari RV; Graeff FG; Pelá IR
Psychopharmacology (Berl); 2000 Jun; 150(3):300-10. PubMed ID: 10923758
[TBL] [Abstract][Full Text] [Related]
9. Increases in plasma corticosterone and stretched-attend postures in rats naive and previously exposed to the elevated plus-maze are sensitive to the anxiolytic-like effects of midazolam.
Albrechet-Souza L; Cristina de Carvalho M; Rodrigues Franci C; Brandão ML
Horm Behav; 2007 Aug; 52(2):267-73. PubMed ID: 17553501
[TBL] [Abstract][Full Text] [Related]
10. Activation of 5-HT(2C) receptors in the dorsal periaqueductal gray increases antinociception in mice exposed to the elevated plus-maze.
Baptista D; Nunes-de-Souza RL; Canto-de-Souza A
Behav Brain Res; 2012 Nov; 235(1):42-7. PubMed ID: 22800924
[TBL] [Abstract][Full Text] [Related]
11. Activity of the medial prefrontal cortex and amygdala underlies one-trial tolerance of rats in the elevated plus-maze.
Albrechet-Souza L; Borelli KG; Brandão ML
J Neurosci Methods; 2008 Mar; 169(1):109-18. PubMed ID: 18190969
[TBL] [Abstract][Full Text] [Related]
12. Age-related qualitative shift in emotional behaviour: paradoxical findings after re-exposure of rats in the elevated-plus maze.
Bessa JM; Oliveira M; Cerqueira JJ; Almeida OF; Sousa N
Behav Brain Res; 2005 Jul; 162(1):135-42. PubMed ID: 15922074
[TBL] [Abstract][Full Text] [Related]
13. Ventrolateral periaqueductal gray lesion attenuates nociception but does not change anxiety-like indices or fear-induced antinociception in mice.
Mendes-Gomes J; Amaral VC; Nunes-de-Souza RL
Behav Brain Res; 2011 Jun; 219(2):248-53. PubMed ID: 21238499
[TBL] [Abstract][Full Text] [Related]
14. Prior maze experience required to alter midazolam effects in rats submitted to the elevated plus-maze.
Bertoglio LJ; Carobrez AP
Pharmacol Biochem Behav; 2002 May; 72(1-2):449-55. PubMed ID: 11900819
[TBL] [Abstract][Full Text] [Related]
15. Anxiogenic-like effects induced by NMDA receptor activation are prevented by inhibition of neuronal nitric oxide synthase in the periaqueductal gray in mice.
Miguel TT; Nunes-de-Souza RL
Brain Res; 2008 Nov; 1240():39-46. PubMed ID: 18793618
[TBL] [Abstract][Full Text] [Related]
16. Central, but not basolateral, amygdala involvement in the anxiolytic-like effects of midazolam in rats in the elevated plus maze.
Carvalho MC; Moreira CM; Zanoveli JM; Brandão ML
J Psychopharmacol; 2012 Apr; 26(4):543-54. PubMed ID: 21148026
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological assessment of the freezing, antinociception, and exploratory behavior organized in the ventrolateral periaqueductal gray.
De Luca-Vinhas MC; Macedo CE; Brandão ML
Pain; 2006 Mar; 121(1-2):94-104. PubMed ID: 16472918
[TBL] [Abstract][Full Text] [Related]
18. Aversive learning as a mechanism for lack of repeated anxiolytic-like effect in the elevated plus-maze.
Stern CA; Carobrez AP; Bertoglio LJ
Pharmacol Biochem Behav; 2008 Oct; 90(4):545-50. PubMed ID: 18533241
[TBL] [Abstract][Full Text] [Related]
19. Activation of 5-HT
Tavares LRR; Baptista-de-Souza D; Canto-de-Souza A
Neuropharmacology; 2018 Jun; 135():376-385. PubMed ID: 29548885
[TBL] [Abstract][Full Text] [Related]
20. Role of learning of open arm avoidance in the phenomenon of one-trial tolerance to the anxiolytic effect of chlordiazepoxide in mice.
Calzavara MB; Patti CL; Lopez GB; Abílio VC; Silva RH; Frussa-Filho R
Life Sci; 2005 Mar; 76(19):2235-46. PubMed ID: 15733938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
